Imel Biotherapeutics
PrivateLast Round
Series A
Nov 15, 2021
Total Funding Raised
$15M
Company Overview
Imel Biotherapeutics is a biotechnology company that develops cell-based therapies designed to treat patients with mitochondrial disorders and age-related indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imel Biotherapeutics Comparables
Compare Imel Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoRx Therapeutics | 57% | |
| PAEAN Biotechnology | 57% | |
| Altos Labs | 56% | |
Imel Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 15, 2021 |
Imel Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shinhan Venture Investment | Series A |
| Korea Investment Partners | Series A |
| Pontifax Venture Capital | Series A |
| Remiges Ventures | Series A |
| Consensus Business Group | Series A |
| Korea Investment Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 15, 2021
$15M round led by Remiges Ventures
Imel Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imel Biotherapeutics's valuation, stock price, and market status.